Open-label phase I clinical trial of Ad5-EBOV in Africans in China

• Main Authors: Lihua Wu (Author), Zhe Zhang (Author), Hainv Gao (Author), Yuhua Li (Author), Lihua Hou (Author), Hangping Yao (Author), Shipo Wu (Author), Jian Liu (Author), Ling Wang (Author), You Zhai (Author), Huilin Ou (Author), Meihua Lin (Author), Xiaoxin Wu (Author), Jingjing Liu (Author), Guanjing Lang (Author), Qian Xin (Author), Guolan Wu (Author), Li Luo (Author), Pei Liu (Author), Jianzhong Shentu (Author), Nanping Wu (Author), Jifang Sheng (Author), Yunqing Qiu (Author), Wei Chen (Author), Lanjuan Li (Author)
• Format: Book
• Published: Taylor & Francis Group, 2017-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: To determine the safety and immunogenicity of a novel recombinant adenovirus type 5 vector based Ebola virus disease vaccine (Ad5-EBOV) in Africans in China. Methods: A phase 1, dose-escalation, open-label trial was conducted. 61 healthy Africans were sequentially enrolled, with 31 parti...